Cargando…
Severe ARDS Secondary to Legionella Pneumonia Requiring VV ECMO in the Setting of Newly Diagnosed Hairy Cell Leukemia
Venovenous (VV) extracorporeal membrane oxygenation (ECMO) for severe acute respiratory distress syndrome (ARDS) is initiated in patients with high mortality as a potential lifesaving intervention. Hematologic malignancy (HM) is considered a relative exclusion criterion by the Extracorporeal Life Su...
Autores principales: | Gorman, Daniel, Green, Adam, Puri, Nitin, Dellinger, Phil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8771749/ https://www.ncbi.nlm.nih.gov/pubmed/35038889 http://dx.doi.org/10.1177/23247096211065618 |
Ejemplares similares
-
Successful use of VV-ECMO in a pregnant patient with severe ARDS()()()
por: Carlier, Laurence, et al.
Publicado: (2019) -
Early vvECMO implantation may be associated with lower mortality in ARDS
por: Rosenberger, Peter, et al.
Publicado: (2023) -
Cryotherapy: A Safe Approach to Pulmonary Hemorrhage During VV-ECMO
por: Green, Adam, et al.
Publicado: (2022) -
(591) Prolonged V.v.-Ecmo for Covid-19 Ards with Lung Recovery
por: Beckett, A., et al.
Publicado: (2023) -
VV-ECMO usage in ARDS due to COVID-19: Clinical, practical and ethical considerations
por: Hoyler, Marguerite M., et al.
Publicado: (2020)